CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
106 hedge funds and large institutions have $4.25B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 35 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 23
9% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 35
Holders
106
Holding in Top 10
3
Calls
$7.79M
Puts
$3.61M
Top Buyers
| 1 | +$94.3M | |
| 2 | +$57.6M | |
| 3 | +$16.7M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$5.95M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$5.11M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$11.9M | |
| 3 | -$11.4M | |
| 4 |
Alkeon Capital Management
New York
|
-$7.41M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.11M |